# A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

> **NCT00964730** · PHASE1 · COMPLETED · sponsor: **Teva Branded Pharmaceutical Products R&D, Inc.** · enrollment: 135 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Talampanel
- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00964730
- **Lead sponsor:** Teva Branded Pharmaceutical Products R&D, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-02
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2010-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00964730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00964730, "A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00964730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*